Intel Currently Up Seven Consecutive Days, On Track for Longest Winning Streak Since September 2023 — Data Talk
Intel Corporation (INTC) is currently at $24.10, up $0.18 or 0.74%
--Would be highest close since Aug. 1, 2024, when it closed at $29.05
--Currently up 10 of the past 11 days
--Currently up seven consecutive days; up 16.01% over this period
--Longest winning streak since Sept. 7, 2023, when it rose for nine straight trading days
--Best seven day stretch since the seven days ending Nov. 20, 2023, when it rose 18.36%
--Up 9.33% month-to-date; on pace for best month since Dec. 2023, when it rose 12.42%
--Down 52.05% year-to-date
--Down 67.82% from its all-time closing high of $74.88 on Aug. 31, 2000
--Down 32.22% from 52 weeks ago (Sept. 29, 2023), when it closed at $35.55
--Down 52.53% from its 52-week closing high of $50.76 on Dec. 27, 2023
--Up 27.56% from its 52-week closing low of $18.89 on Sept. 6, 2024
--Traded as high as $24.66; highest intraday level since Aug. 1, 2024, when it hit $30.71
--Up 3.09% at today's intraday high
--Second most active stock in the S&P 500 today
--Second most active stock in the Nasdaq 100 today
--Contributed 1.18 points to the DJIA so far today
All data as of 11:03:17 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 27, 2024 11:20 ET (15:20 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks